4D Molecular Therapeutics (FDMT) Interest & Investment Income: 2020-2025
Historic Interest & Investment Income for 4D Molecular Therapeutics (FDMT) over the last 6 years, with Sep 2025 value amounting to $4.3 million.
- 4D Molecular Therapeutics' Interest & Investment Income fell 40.60% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.2 million, marking a year-over-year decrease of 14.92%. This contributed to the annual value of $27.1 million for FY2024, which is 121.52% up from last year.
- According to the latest figures from Q3 2025, 4D Molecular Therapeutics' Interest & Investment Income is $4.3 million, which was down 10.89% from $4.9 million recorded in Q2 2025.
- In the past 5 years, 4D Molecular Therapeutics' Interest & Investment Income registered a high of $7.5 million during Q2 2024, and its lowest value of -$312,000 during Q4 2021.
- Its 3-year average for Interest & Investment Income is $4.9 million, with a median of $4.9 million in 2025.
- Data for 4D Molecular Therapeutics' Interest & Investment Income shows a peak YoY increase of 10,775.00% (in 2021) and a maximum YoY decrease of 7,900.00% (in 2021) over the last 5 years.
- Quarterly analysis of 5 years shows 4D Molecular Therapeutics' Interest & Investment Income stood at -$312,000 in 2021, then spiked by 528.85% to $1.3 million in 2022, then surged by 227.35% to $4.4 million in 2023, then spiked by 47.65% to $6.5 million in 2024, then slumped by 40.60% to $4.3 million in 2025.
- Its Interest & Investment Income was $4.3 million in Q3 2025, compared to $4.9 million in Q2 2025 and $5.6 million in Q1 2025.